<ul><li>Akido Labs Inc. has secured $60 million in new funding to expand ScopeAI, an AI system aimed at enhancing clinical capacity and improving healthcare access for underserved populations.</li><li>Founded in 2015, Akido utilizes AI-powered software and a network of multispecialty clinics to provide efficient, whole-person care at scale, with a focus on enabling access to high-quality care for vulnerable communities.</li><li>ScopeAI is an AI-driven clinical co-pilot that helps medical assistants and physicians by generating clinical questions, capturing patient responses in real time, and drafting documentation to reduce administrative burdens on healthcare providers.</li><li>The Series B funding round was led by Oak HC/FT Partners LP, with participation from Greco Risk Partners, SNR Denton Group Ltd., and existing investors like Y Combinator and Google's Jeff Dean. Akido aims to address the global doctor shortage by leveraging AI to empower healthcare providers and improve patient care.</li></ul>

Akido lands $60M to grow AI platform for underserved healthcare settings

Discover more